EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance



Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance



Cancer Research 55(20): 4711-4716



Recent evidence suggests that resistance to antineoplastic therapy may result from mutations in genes mediating the apoptotic response to DNA damage. To determine the effects of epigenetic changes on tumor responsiveness to cytotoxic agents inducing DNA damage, we examined the chemosensitivity of neuroblastoma (NB) after differentiation by retinoic acid (RA). Differentiation of the cell lines SH-SY5Y and SMS-KCNR by RA abolished the cytotoxic effects of adriamycin (Adr) and cisplatin. Chemoresistance was not the result of decreased proliferation induced by RA because: (a) growth arrest by nutrient deprivation did not affect sensitivity; (b) growth arrested NB cell lines, which did not differentiate, remained chemosensitive; and (c) RA concentrations which promoted differentiation without affecting growth, induced resistance. Apoptosis characterized NB cells responding to Adr, although differentiated SH-SY5Y did not apoptose and were resistant to Adr and cisplatin. Marked induction of bcl-2 in NB cells followed RA-induced differentiation, whereas in cell lines failing to differentiate, bcl-2 was not detected. Our data indicate that NB differentiation induces drug resistance after a loss of the apoptotic response to antineoplastic drugs and suggest that bcl-2 overexpression is an important mechanism of resistance in differentiated tumor cells.

(PDF emailed within 1 workday: $29.90)

Accession: 008476731

Download citation: RISBibTeXText

PMID: 7553653



Related references

Inhibition of multidrug resistance-associated protein expression in neuroblastoma cells induces spontaneous differentiation, apoptosis and reduced Bcl-2 expression. Proceedings of the American Association for Cancer Research Annual Meeting 40: 224, March, 1999

Epothilone A induces apoptosis in neuroblastoma cells with multiple mechanisms of drug resistance. International Journal of Oncology 11(1): 123-126, 1997

Lovastatin induces neuronal differentiation and apoptosis of embryonal carcinoma and neuroblastoma cells: enhanced differentiation and apoptosis in combination with dbcAMP. Molecular and Cellular Biochemistry 345(1-2): 1-11, 2011

Resveratrol enhances the expression of death receptor Fas/CD95 and induces differentiation and apoptosis in anaplastic large-cell lymphoma cells. Cancer Letters 309(1): 46-53, 2011

All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells. Cell Growth & Differentiation 13(8): 343-354, 2002

Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation. Molecular and Cellular Biology 9(10): 4337-4344, 1989

Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma. American Journal of Pathology 154(2): 395-403, 1999

MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Biochemical and Biophysical Research Communications 351(1): 192-197, 2006

The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells. Cancer Letters 281(2): 171-182, 2009

PrP 106-126 induces apoptosis in 5H-SY-5Y neuroblastoma cells effects of differentiation and intracellular mechanisms involved. Society for Neuroscience Abstracts 26(1-2): Abstract No -93 7, 2000

Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells. Leukemia & Lymphoma 45(5): 997-1008, 2004

Interleukin-24 induces neuroblastoma SH-SY5Y cell differentiation, growth inhibition, and apoptosis by promoting ROS production. Journal of Interferon & Cytokine Research 33(11): 709-714, 2014

Interferon-gamma induces a dual and alternative early biological response in neuroblastoma cells Differentiation and apoptosis. Biochemical Society Transactions 24(4): 551S, 1996

Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis. Human Molecular Genetics 22(9): 1735-1745, 2013

Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. Cell Growth & Differentiation 6(11): 1387-1394, 1995